Details
Zusammenfassung: <jats:title>Abstract</jats:title><jats:sec><jats:label /><jats:p>Coronary artery disease (<jats:styled-content style="fixed-case">CAD</jats:styled-content>) and aortic stenosis (<jats:styled-content style="fixed-case">AS</jats:styled-content>) frequently coexist. The advent of transcatheter aortic valve implantation (<jats:styled-content style="fixed-case">TAVI</jats:styled-content>) and its increased use over the last decade has brought a paradigm shift in the management of patients with severe <jats:styled-content style="fixed-case">AS</jats:styled-content> who are considered inoperable or high risk for <jats:styled-content style="fixed-case">sAVR</jats:styled-content>. The most appropriate management of coexistent <jats:styled-content style="fixed-case">CAD</jats:styled-content> in patients undergoing <jats:styled-content style="fixed-case">TAVI</jats:styled-content> is yet to be defined. In this article, we present a review of the issues arising in the management of <jats:styled-content style="fixed-case">CAD</jats:styled-content> in patients with severe <jats:styled-content style="fixed-case">AS</jats:styled-content>—with particular reference to those who are undergoing <jats:styled-content style="fixed-case">TAVI</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:label /><jats:p><jats:bold>Answer questions and earn CME:</jats:bold> <jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://wileyhealthlearning.com/Activity2/5222680/Activity.aspx">https://wileyhealthlearning.com/Activity2/5222680/Activity.aspx</jats:ext-link></jats:p></jats:sec>
Umfang: 4-10
ISSN: 2059-1594
DOI: 10.1002/cce2.47